Johns Hopkins Undergraduate Research Travel Exception Form
Under general university guidance, KSAS will allow only essential university-sponsored travel, which must be approved by the dean's office. Affiliates will be required to submit travel approval documentation with their expense reports.
The Krieger School Dean’s Office has the latitude to make the decision about what is essential for the division, which may be defined as having:
- High strategic importance to further or maintain the interests of the Krieger School or the department.
- High consequence to the school or department for breaking a previously established commitment.
- Real and tangible impact to undergraduate students for professional development, degree completion, and other options to accomplish the goal are not feasible.
- No alternative form for participation.
Considerations for denial of requests:
- Does not meet the criteria noted above.
- Although the person making the request may adhere to appropriate precautions, many travel meetings attract participants from all over the country and possibly the world with varying prevalence of COVID-19 transmission, heterogeneous views on masking and other precautions, and unreliable acceptance of the COVID-19 vaccine.
- Should the traveling individual become ill, is the local medical care sufficiently reliable and up to standard? Is there a reasonable likelihood the individual can be repatriated to Maryland (even if the meeting is stateside)?
- If the individual allowed to go becomes infected and needs to recover over a period of time—possibly even prolonged—they will be responsible for maintaining their coursework and university commitments. This effect is more pronounced and the risks significantly greater if a group travels and experiences similar exposure simultaneously.
- Travel settings are not as well-controlled as within Johns Hopkins-owned and operated settings, with our COVID measures in place. COVID rates and hospitalizations continue to rise in the U.S. and many parts of the world. The death toll in the U.S. is again well over 1,000 individuals a day, and there are more than 150,000 new infections per day. Projections indicate that we have not yet reached a peak.